Stock A063160 CKD BIO CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company CKD Bio Corp.

Equities

A063160

KR7063160006

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
23,900 KRW -1.24% Intraday chart for CKD Bio Corp. -1.04% +0.21%
2023 CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 CKD Bio Corp.(KOSE:A063160) dropped from S&P Global BMI Index CI

Business Summary

CKD Bio Corp. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company mainly provides antibiotic ingredients, consisting of demethylchlortetracyclines (DMCTs) and rifampicins. It also provides immunosuppressive agents, including cyclosporin and tacrolimus; remedies for diabetes, such as acarbose, and potassium clavulanate used for beta-lactam inhibitors. The Company distributes its products within domestic market and to overseas markets, such as America, China, Europe, Africa, Southeast Asia, Latin America and the Middle East.

Number of employees: 519

Sales per Business

KRW in Million2022Weight2023Weight Delta
Drug Substance
83.5 %
125,090 80.2 % 133,933 83.5 % +7.07%
Probiotics
11.9 %
24,982 16.0 % 19,056 11.9 % -23.72%
Botulinum Toxin
4.6 %
5,971 3.8 % 7,363 4.6 % +23.32%

Sales per region

KRW in Million2022Weight2023Weight Delta
Europe
35.1 %
37,364 23.9 % 56,279 35.1 % +50.62%
Asia
23.5 %
48,622 31.2 % 37,643 23.5 % -22.58%
South Korea
23.2 %
45,919 29.4 % 37,175 23.2 % -19.04%
Others
10.2 %
17,345 11.1 % 16,354 10.2 % -5.71%
Middle East
8.0 %
6,793 4.4 % 12,902 8.0 % +89.94%

Managers

Managers TitleAgeSince
Jeong-Jin Lee CEO
 Chief Executive Officer 59 -
Jin-Hyo Jung BRD
 Director/Board Member 62 15-03-19
Han-Joon Kim PRN
 Corporate Officer/Principal 63 -
Dong-Myeong Ahn AUD
 Comptroller/Controller/Auditor 68 14-03-20
Jang-Han Lee PRN
 Corporate Officer/Principal 71 -

Members of the board

Members of the board TitleAgeSince
Jang-Han Lee PRN
 Corporate Officer/Principal 71 -
Jeong-Jin Lee CEO
 Chief Executive Officer 59 -
Jin-Hyo Jung BRD
 Director/Board Member 62 15-03-19
In-Kyu Kim BRD
 Director/Board Member 66 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,485,962 3,337,770 ( 60.84 %) 3 ( 0.000055 %) 60.84 %

Shareholders

NameEquities%Valuation
CHONG KUN DANG HOLDINGS CORP.
39.11 %
2,145,328 39.11 % 38 M ₩
DFA Australia Ltd.
0.0116 %
636 0.0116 % 11 315 ₩
Dimensional Fund Advisors Ltd.
0.0101 %
556 0.0101 % 9 891 ₩
Mirae Asset Global Investments Co., Ltd.
0.003956 %
217 0.003956 % 3 860 ₩
Korea Investment Management Co., Ltd.
0.000365 %
20 0.000365 % 356 ₩
CKD BIO CORP.
0.000036 %
2 0.000036 % 36 ₩

Holdings

NameEquities%Valuation
CKD BIO CORP.
0.00%
 2 0.00% 36 $

Company contact information

CKD Bio Corp.

Chongkundang Building 8 Chungjeong-ro

03742, Seoul

+82 2 2194 0555

http://www.ckdbio.com
address CKD Bio Corp.(A063160)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
CKD BIO CORP. Stock CKD Bio Corp.
+0.21% 96.78M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A063160 Stock
  4. Company CKD Bio Corp.